Allianz Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-109,513
| Closed | -$2.65M | – | 1668 |
|
|
2022
Q2 | $2.65M | Buy |
109,513
+45,793
| +72% | +$1.11M | ﹤0.01% | 1212 |
|
|
2022
Q1 | $1.64M | Buy |
63,720
+3,900
| +7% | +$100K | ﹤0.01% | 1425 |
|
|
2021
Q4 | $1.85M | Buy |
+59,820
| New | +$1.85M | ﹤0.01% | 1422 |
|
|
2021
Q2 | – | Sell |
-14,635
| Closed | -$365K | – | 2004 |
|
|
2021
Q1 | $365K | Sell |
14,635
-68,985
| -82% | -$1.72M | ﹤0.01% | 1758 |
|
|
2020
Q4 | $2.28M | Buy |
83,620
+13,507
| +19% | +$368K | ﹤0.01% | 1259 |
|
|
2020
Q3 | $1.29M | Sell |
70,113
-6,463
| -8% | -$119K | ﹤0.01% | 1350 |
|
|
2020
Q2 | $1.56M | Buy |
+76,576
| New | +$1.56M | ﹤0.01% | 1332 |
|
|
2019
Q4 | – | Sell |
-34,646
| Closed | -$407K | – | 2304 |
|
|
2019
Q3 | $407K | Buy |
34,646
+8,540
| +33% | +$100K | ﹤0.01% | 1948 |
|
|
2019
Q2 | $525K | Sell |
26,106
-1,669
| -6% | -$33.6K | ﹤0.01% | 1907 |
|
|
2019
Q1 | $628K | Buy |
27,775
+2,625
| +10% | +$59.4K | ﹤0.01% | 1889 |
|
|
2018
Q4 | $566K | Buy |
+25,150
| New | +$566K | ﹤0.01% | 1819 |
|